查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1961410

女性应力性尿失禁治疗设备市场－全球产业规模、份额、趋势、机会、预测：按产品类型、最终用户、地区和竞争对手划分，2021-2031年

Female Stress Urinary Incontinence Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End-user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球女性应力性尿失禁(SUI) 治疗设备市场预计将从 2025 年的 7.8303 亿美元增长到 2031 年的 12.0913 亿美元，复合年增长率为 7.51%。

阴道托、尿道隔膜吊带和尿道填充物等专业医疗产品旨在透过加强膀胱颈或改善运动时的尿道闭合功能来恢復尿失禁。该领域的成长主要受人口结构变化所驱动，尤其是老年女性数量的增加和肥胖率的上升，这两者都是骨盆底肌肉无力的主要风险因素。此外，微创手术方式的日益普及以及患者对有效治疗策略的教育加强也推动了市场的发展。

市场概览
预测期 2027-2031
市场规模：2025年 7.8303亿美元
市场规模：2031年 12.0913亿美元
复合年增长率：2026-2031年 7.51%
成长最快的细分市场 尿道吊带
最大的市场 北美洲

这种强劲的需求也体现在其高发病率上，凸显了临床解决方案的迫切性。根据2025年版《美国泌尿外科协会新闻》（AUANews）的报道，「应力性尿失禁是最常见的尿失禁类型，在积极参与体育锻炼的女性中，其患病率超过40%。」儘管市场前景光明，但由于严格的监管标准以及关于经阴道网植入安全性的持续诉讼，该市场面临着诸多挑战。这些问题不断削弱人们对外科医师的信心，并降低患者接受网片植入手术的意愿。

市场驱动因素

女性应力性尿失禁(SUI) 发生率的不断上升是推动该医疗器材市场发展的主要动力，在全球范围内扩大了临床需求。生活方式因素和女性人口老化加剧了这种人口压力，促使人们寻求更广泛的治疗性介入。此疾病的庞大规模迫使医疗服务提供者专注于可扩展的解决方案，从尿道填充剂到先进的外科植入。为了应对这一广泛的负担，UroMems 公司在 2024 年 6 月宣布：“UroMems 完成创纪录的 4700 万美元 C 轮资金筹措”，应力性尿失禁影响着约 4000 万美国人和 9000 万欧洲人。如此庞大的患者群体强烈表明，需要有效的管理策略，而这需要医疗专业人员的统计数据支持。根据国际尿控协会的数据，到 2024 年，工作年龄层专业女性的尿失禁盛行率将超过 25%，这表明该疾病正在从老年人蔓延到活跃人群。

同时，智慧穿戴技术的引进正以其非侵入式、居家式的替代方案改变着市场格局。随着患者越来越倾向于选择更隐密、更便捷的治疗方案而非手术，製造商正将数位连接和生物回馈疗法机制整合到骨盆底肌训练设备中，以改善临床疗效和提高治疗依从性。这种向数位化疗法的转变弥补了传统保守治疗的不足，提供了进展追踪和即时视觉化功能。 Axena Health 于 2024 年 7 月发布的题为《Axena Health 发布新的真实世界证据，进一步增强 Leva 骨盆底健康系统》的报告证实了这些现代方法的有效性，其中 74% 的参与者在使用该系统后症状得到改善。这些创新不仅提高了患者的生活质量，也促进了基于设备的治疗方法作为一线标准治疗方案的广泛接受。

市场挑战

严格的监管标准和持续不断的关于经阴道网植入安全性的诉讼，是全球女性应力性尿失禁（SUI）治疗器械市场发展的主要障碍。这种复杂的市场情况削弱了外科医生的信心，并因担心面临巨额赔偿诉讼而阻碍了製造商积极研发产品，从而抑制了市场成长。随着监管审查的加强以及医疗设备认证对更可靠的临床数据的需求，企业面临更高的合规成本和更长的上市週期。因此，这些法律法规的变化正在改变临床实践模式，导致许多医疗机构优先考虑保守治疗策略，并减少使用网路医疗设备。

近期产业数据显示，安全隐患正在产生持久影响，这也印证了手术数量的下降趋势。据美国泌尿系统协会称，「在所分析的人群中，压力性尿失禁患者接受吊带手术的比例将持续下降，到2024年约为2.0%。」这一趋势表明，儘管压力性尿失禁十分普遍，但对法律影响和监管障碍的担忧确实限制了市场规模，并抑制了患者对该设备的接受度。

市场趋势

高强度聚焦电磁（HIFEM）椅式疗法的兴起正日益重塑市场格局，它提供了一种完全被动、非侵入性的治疗选择，与主动式物理治疗截然不同。传统的保守治疗和生物回馈疗法系统依赖患者的依从性和努力，而HIFEM技术则利用电磁能量，在一次住院治疗中即可产生数千次超强骨盆底肌收缩。这确保了治疗效果的持续性，且不会对患者造成身体负担。这项技术正迅速获得商业性认可，因为它满足了临床医生对有效、零恢復期解决方案的需求，尤其适用于那些对手术犹豫不决或难以坚持自主运动的患者。为了佐证这一增长，《美容医学从业者》杂誌2024年12月刊发表了报导，报道称BTL Aesthetics仅在亚太地区就安装了超过500台Emsella设备，凸显了这种椅式疗法在全球范围内受到医疗保健机构的广泛关注和支持。

同时，在消费者对非临床环境下即时、按需缓解症状的需求日益增长的推动下，一次性非处方（OTC）阴道支撑垫的普及呈现出明显的趋势。这些机械装置能够为尿道提供隐藏的结构支撑，尤其是在运动期间，有效弥合了永久性手术植入和可吸收垫之间的治疗差距，从而帮助女性自主管理自身病情。这一趋势象征着医疗保健的民主化，从僵化的处方笺模式转向易于获取、患者可自行管理的解决方案，无需长期医疗承诺。例如，根据2025年4月发表在《医疗产品外包》（Medical Product Outsourcing）报导上的一篇文章《Uresta宣布在美国推出新型膀胱支撑解决方案》，Uresta成功资金筹措了300万美元，以加速其可重复使用膀胱支撑装置的商业化进程。这反映了该行业正朝着扩充性的、以消费者为导向的创新方向发展。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：女性应力性尿失禁（SUI）治疗器械的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品类型（尿道吊带、导尿管、阴道托、其他）
    • 按最终使用者（医院/门诊手术中心 (ASC)、专科诊所、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美女性应力性尿失禁（SUI）治疗器械市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲女性应力性尿失禁（SUI）治疗器材市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区女性应力性尿失禁（SUI）治疗器材市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲女性应力性尿失禁的市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美女性应力性尿失禁（SUI）治疗器械市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章 全球女性应力性尿失禁（SUI）治疗设备市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Coloplast
  • Boston Scientific
  • Cook Medical
  • Axonics
  • Neomedic
  • Mentor
  • Hollister
  • AM Surgical
  • Uroplasty Lines

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 26751

The Global Female Stress Urinary Incontinence (SUI) Devices Market is projected to expand from USD 783.03 Million in 2025 to USD 1209.13 Million by 2031, registering a CAGR of 7.51%. These specialized medical products, which include vaginal pessaries, midurethral slings, and urethral bulking agents, are engineered to restore continence by reinforcing the bladder neck or improving urethral closure during physical activity. Growth in this sector is fundamentally fueled by demographic changes, particularly the increasing population of aging women and rising obesity rates, both of which are major risk factors for pelvic floor weakness. Additionally, the market is being propelled by a growing inclination toward minimally invasive surgical options and enhanced patient education regarding effective management strategies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 783.03 Million
Market Size 2031USD 1209.13 Million
CAGR 2026-20317.51%
Fastest Growing SegmentUrethral Slings
Largest MarketNorth America

This strong demand is reinforced by significant prevalence rates that emphasize the urgent need for clinical solutions. According to 'AUANews' in '2025', 'stress urinary incontinence is the most common type of urinary incontinence with a prevalence of over 40% in females who actively participate in physical activities'. Despite these favorable growth prospects, the market confronts considerable obstacles stemming from strict regulatory standards and persistent litigation concerning the safety of transvaginal mesh implants. These issues continue to undermine surgeon confidence and reduce patient willingness to consent to mesh-based procedures.

Market Driver

The increasing incidence of female stress urinary incontinence (SUI) acts as a primary catalyst for the devices market, generating growing clinical demand worldwide. This demographic strain, heightened by lifestyle factors and an aging female population, requires a wider array of therapeutic interventions. The magnitude of this condition compels healthcare providers to focus on scalable solutions, extending from urethral bulking agents to sophisticated surgical implants. Underscoring this extensive burden, according to UroMems, June 2024, in the 'UroMems Raises Record $47 million in Series C Financing' press release, stress urinary incontinence affects an estimated 40 million Americans and 90 million Europeans. This significant patient population highlights the vital need for effective management strategies, a point further bolstered by workforce statistics; according to the International Continence Society, in 2024, the prevalence of urinary incontinence in working-age professional women is greater than 25%, showing that the condition spans active populations rather than being restricted to the geriatric demographic.

Concurrently, the incorporation of smart and wearable technologies is transforming the market by enabling non-invasive, home-based therapeutic alternatives. As patients increasingly prefer discreet and convenient options over surgery, manufacturers are integrating digital connectivity and biofeedback mechanisms into pelvic floor muscle training devices to improve clinical outcomes and adherence. This movement toward digital therapeutics mitigates the shortcomings of conventional conservative treatments by offering progress tracking and real-time visualization. Confirming the effectiveness of these modern approaches, according to Axena Health, July 2024, in the 'Axena Health shares new publication that adds more real-world evidence for the Leva Pelvic Health System' announcement, 74 percent of participants using the system experienced symptom improvement. Such innovations not only enhance patient quality of life but also promote the broader acceptance of device-based therapies as a standard first-line treatment.

Market Challenge

Rigorous regulatory standards and continuing litigation concerning the safety of transvaginal mesh implants constitute a major barrier to the advancement of the Global Female Stress Urinary Incontinence (SUI) Devices Market. This complicated landscape inhibits growth by undermining surgeon confidence and discouraging manufacturers from pursuing aggressive product development due to the risk of significant liability claims. As regulatory authorities increase scrutiny and necessitate more robust clinical data for device approval, companies encounter rising compliance costs and extended timelines for market entry. Consequently, this volatility in the legal and regulatory sphere has altered clinical practice patterns, leading many healthcare providers to decrease their use of mesh-based devices in favor of conservative management strategies.

This reduction in procedural volume is demonstrated by recent industry data that underscores the enduring effect of these safety concerns. According to the 'American Urological Association', in '2024', 'the percentage of patients with stress urinary incontinence who underwent a sling procedure continued to decline to roughly 2.0% within the analyzed population'. Such trends suggest that the fear of legal repercussions and regulatory obstacles effectively constrains the addressable market, restricting patient adoption of these devices despite the widespread prevalence of the condition.

Market Trends

The rise of High-Intensity Focused Electromagnetic (HIFEM) Chair Therapies is increasingly shaping the market, providing a fully passive, non-invasive treatment option that differs significantly from active physical therapy. In contrast to traditional conservative management or biofeedback systems that depend on patient compliance and effort, HIFEM technology uses electromagnetic energy to generate thousands of supramaximal pelvic floor muscle contractions during a single in-office session, ensuring consistent therapeutic results without physical exertion. This technology is experiencing fast commercial adoption as clinicians aim to provide effective, zero-downtime solutions for patients who are reluctant to undergo surgery or struggle with voluntary exercise routines. Confirming this growth, according to Aesthetic Medical Practitioner, December 2024, in the 'BTL wins Best Non-Invasive Body Shaping Manufacturer' article, BTL Aesthetics reported having installed over 500 Emsella devices across the Asia-Pacific region alone, highlighting the substantial global traction and provider acceptance of this chair-based therapy.

At the same time, there is a distinct movement toward Disposable and Over-the-Counter (OTC) Vaginal Support Inserts, fueled by rising consumer demand for immediate, on-demand symptom management outside of clinical environments. These mechanical devices offer discreet structural support to the urethra specifically during physical activity, effectively bridging the therapeutic divide between permanent surgical implants and absorbent pads for women desiring autonomy in managing their condition. This trend represents a democratization of care, shifting away from strictly prescription-based models toward accessible, patient-controlled solutions that can be acquired and used without long-term medical commitments. Emphasizing the investment interest in this sector, according to Medical Product Outsourcing, April 2025, in the 'Uresta Debuts New Bladder Support Solution in U.S.' article, Uresta secured $3 million in funding to accelerate the commercialization of its reusable bladder support device, mirroring the industry's shift toward scalable, consumer-focused innovations.

Key Market Players

  • Coloplast
  • Boston Scientific
  • Cook Medical
  • Axonics
  • Neomedic
  • Mentor
  • Hollister
  • A.M. Surgical
  • Uroplasty Lines

Report Scope

In this report, the Global Female Stress Urinary Incontinence (SUI) Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Female Stress Urinary Incontinence (SUI) Devices Market, By Product Type

  • Urethral Slings
  • Catheters
  • Vaginal Pessaries
  • Others

Female Stress Urinary Incontinence (SUI) Devices Market, By End-user

  • Hospitals & Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Others

Female Stress Urinary Incontinence (SUI) Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Female Stress Urinary Incontinence (SUI) Devices Market.

Available Customizations:

Global Female Stress Urinary Incontinence (SUI) Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Urethral Slings, Catheters, Vaginal Pessaries, Others)
    • 5.2.2. By End-user (Hospitals & Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End-user
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End-user
    • 6.3.2. Canada Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End-user
    • 6.3.3. Mexico Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End-user

7. Europe Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End-user
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End-user
    • 7.3.2. France Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End-user
    • 7.3.3. United Kingdom Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End-user
    • 7.3.4. Italy Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End-user
    • 7.3.5. Spain Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End-user

8. Asia Pacific Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End-user
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End-user
    • 8.3.2. India Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End-user
    • 8.3.3. Japan Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End-user
    • 8.3.4. South Korea Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End-user
    • 8.3.5. Australia Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End-user

9. Middle East & Africa Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End-user
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End-user
    • 9.3.2. UAE Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End-user
    • 9.3.3. South Africa Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End-user

10. South America Female Stress Urinary Incontinence (SUI) Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End-user
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End-user
    • 10.3.2. Colombia Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End-user
    • 10.3.3. Argentina Female Stress Urinary Incontinence (SUI) Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End-user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Female Stress Urinary Incontinence (SUI) Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Coloplast
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Boston Scientific
  • 15.3. Cook Medical
  • 15.4. Axonics
  • 15.5. Neomedic
  • 15.6. Mentor
  • 15.7. Hollister
  • 15.8. A.M. Surgical
  • 15.9. Uroplasty Lines

16. Strategic Recommendations

17. About Us & Disclaimer